How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?

Journal of Law, Medicine and Ethics 48 (1):44-68 (2020)
  Copy   BIBTEX


Delivering high quality genomics-informed care to patients requires accurate test results whose clinical implications are understood. While other actors, including state agencies, professional organizations, and clinicians, are involved, this article focuses on the extent to which the federal agencies that play the most prominent roles — the Centers for Medicare and Medicaid Services enforcing CLIA and the FDA — effectively ensure that these elements are met and concludes by suggesting possible ways to improve their oversight of genomic testing.



    Upload a copy of this work     Papers currently archived: 89,408

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

The Streetlight Effect: Regulating Genomics Where the Light Is.Barbara J. Evans - 2020 - Journal of Law, Medicine and Ethics 48 (1):105-118.
Genomic Testing and Genomic Care: Are They Talking to Each Other?Julian Barwell & Anirudh Kumar - 2015 - Journal of Clinical Research and Bioethics 6 (6).
Quality Improvement Ethics: Lessons From the SUPPORT Study.Benjamin S. Wilfond - 2013 - American Journal of Bioethics 13 (12):14-19.
The concept of quality in clinical research.Dorota Śwituła - 2006 - Science and Engineering Ethics 12 (1):147-156.


Added to PP

10 (#1,013,160)

6 months
3 (#426,595)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Susan Wolf
University of North Carolina, Chapel Hill
Ralph Hall
Virginia Tech